Cell therapy in vascularized composite allotransplantation

Cell therapy in vascularized composite allotransplantation

Allograft rejection is one of the obstacles in achieving a successful vascularized composite allotransplantation (VCA). Treatments of graft rejection with lifelong immunosuppression (IS) subject the recipients to a lifelong risk of cancer development and opportunistic infections. Cell therapy has re...

Full description

Bibliographic Details
Main Authors: Madonna Rica Anggelia, Hui-Yun Cheng, Ping-Chin Lai, Yun-Huan Hsieh, Chih-Hung Lin, Cheng-Hung Lin
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biomedical Journal
Subjects:
Vascularized composite allotransplantation
Clinical transplantation
Cell therapy
Stem cell
Immune cell
Online Access:http://www.sciencedirect.com/science/article/pii/S2319417022000051

Internet

http://www.sciencedirect.com/science/article/pii/S2319417022000051

Similar Items